Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Clin Virol. 2019 Sep 16;120:44–50. doi: 10.1016/j.jcv.2019.08.011

Table 3.

Clinical Performance of CII-ArboViroPlex rRT-PCR assay for ZIKV, DENV, CHIKV and WNV in Serum and for ZIKV in urine

Category ZIKV Positive DENV Positive CHIKV Positive WNV Positive
Positive Controls
ZIKV Positive (Serum) n=41
CII ArboViroPlex 39/41* 0/41 0/41 0/41
Comparator assays# 41/41 0/41 0/41 0/41
ZIKV Positive (Urine) n=26
CII ArboViroPlex 25/26* 0/26 0/26 0/26
Comparator assays# 26/26 0/26 0/26 0/26
DENV Positive (n=24 serum)
CII ArboViroPlex 0/24 24/24 0/24 0/24
Comparator assays# 0/24 24/24 0/24 0/24
CHIKV Positive (n=20 serum)
CII ArboViroPlex 0/20 0/20 20/20 0/20
Comparator assays# 0/20 0/20 20/20 0/20
WNV Positive (n=19 serum)
CII ArboViroPlex 0/19 0/19 0/19 19/19
Comparator assays# 0/19 0/19 0/19 19/19
Negative Controls
Negative Controls(n=61 serum)
CII ArboViroPlex 0/61 0/61 0/61 0/61
Comparator assays# 0/61 0/61 0/61 0/61
Negative (n=50 urine)
CII ArboViroPlex 0/50 0/50 0/50 0/50
Comparator assays# 0/50 0/50 0/50 0/50
Positive agreement (Serum) (39/41) (24/24) (20/20) (19/19)
Positive % agreement 95.10% 100.00% 100.00% 100.00%
95% CI 89.8–99.2% 93.5–100.0% 92.3–100.0% 92.1–100.0%
Negative agreement (Serum) (124/124) (141/141) (145/145) (146/146)
Negative % agreement 100.00% 100.00% 100.00% 100.00%
95% CI 97.1–100.0% 96.1–99.9% 97.5–100.0% 97.5–100.0%
Positive agreement (Urine) (25/26) NA NA NA
Positive percent agreement 96.20%
95% CI 89.9–99.7%
Neative agreement (Urine) 100% NA NA NA
Negative % agreement (50/50)
95% CI 92.9–100.0%

Includes clinical positive specimens for other viral targets as additional negatives, e.g. for Zika virus the CHIKV, DENV and WNV positive specimens were included as negatives in the Zika virus performance.